NGM Annual Non Current Assets
$12.42 M
-$6.12 M-33.00%
31 December 2023
Summary:
As of January 20, 2025, NGM annual long term assets is $12.42 million, with the most recent change of -$6.12 million (-33.00%) on December 31, 2023. During the last 3 years, it has fallen by -$8.19 million (-39.74%).NGM Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Quarterly Non Current Assets
$12.42 M
-$2.69 M-17.79%
31 December 2023
Summary:
As of January 20, 2025, NGM quarterly long term assets is $12.42 million, with the most recent change of -$2.69 million (-17.79%) on December 31, 2023. Over the past year, it has dropped by -$3.88 million (-23.82%).NGM Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.0% | -23.8% |
| 3 y3 years | -39.7% | -39.7% |
| 5 y5 years | -60.6% | -60.6% |
NGM Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -83.1% | -83.1% |
NGM Biopharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $156.44 M(-45.8%) | $12.42 M(-17.8%) |
| Sept 2023 | - | $15.11 M(-6.4%) |
| June 2023 | - | $16.14 M(-1.0%) |
| Mar 2023 | - | $16.31 M(-12.1%) |
| Dec 2022 | $288.86 M(-23.8%) | $18.54 M(-8.0%) |
| Sept 2022 | - | $20.17 M(+8.8%) |
| June 2022 | - | $18.53 M(-16.3%) |
| Mar 2022 | - | $22.15 M(-4.1%) |
| Dec 2021 | $379.28 M(+23.0%) | $23.11 M(+15.7%) |
| Sept 2021 | - | $19.98 M(+0.5%) |
| June 2021 | - | $19.88 M(+1.0%) |
| Mar 2021 | - | $19.69 M(-4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $308.43 M(-13.2%) | $20.62 M(-13.5%) |
| Sept 2020 | - | $23.84 M(-3.3%) |
| June 2020 | - | $24.66 M(+10.1%) |
| Mar 2020 | - | $22.39 M(-11.0%) |
| Dec 2019 | $355.25 M(+65.6%) | $25.16 M(-4.3%) |
| Sept 2019 | - | $26.30 M(-7.3%) |
| June 2019 | - | $28.36 M(-12.7%) |
| Mar 2019 | - | $32.48 M(+3.0%) |
| Dec 2018 | $214.56 M(+22.2%) | $31.53 M(-31.6%) |
| June 2018 | - | $46.09 M(-37.2%) |
| Dec 2017 | $175.53 M(-25.2%) | $73.41 M |
| Dec 2016 | $234.68 M | - |
FAQ
- What is NGM Biopharmaceuticals annual long term assets?
- What is the all time high annual non current assets for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual non current assets year-on-year change?
- What is NGM Biopharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly non current assets year-on-year change?
What is NGM Biopharmaceuticals annual long term assets?
The current annual non current assets of NGM is $12.42 M
What is the all time high annual non current assets for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual long term assets is $73.41 M
What is NGM Biopharmaceuticals annual non current assets year-on-year change?
Over the past year, NGM annual long term assets has changed by -$6.12 M (-33.00%)
What is NGM Biopharmaceuticals quarterly long term assets?
The current quarterly non current assets of NGM is $12.42 M
What is the all time high quarterly non current assets for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly long term assets is $73.41 M
What is NGM Biopharmaceuticals quarterly non current assets year-on-year change?
Over the past year, NGM quarterly long term assets has changed by -$3.88 M (-23.82%)